高等学校化学学报 ›› 2014, Vol. 35 ›› Issue (2): 262.doi: 10.7503/cjcu20130625
刘祈星1,2, 胡艾希1(), 王晓光2, 雷满香2, 欧晓明2, 任叶果2, 黄路2, 柳爱平2(
)
收稿日期:
2013-07-04
出版日期:
2014-02-10
发布日期:
2014-01-02
作者简介:
联系人简介: 胡艾希, 男, 博士, 教授, 博士生导师, 主要从事药物化学研究. E-mail:基金资助:
LIU Qixing1,2, HU Aixi1,*(), WANG Xiaoguang2, LEI Manxiang2, OU Xiaoming2, REN Yeguo2, HUANG Lu2, LIU Aiping2,*(
)
Received:
2013-07-04
Online:
2014-02-10
Published:
2014-01-02
Contact:
HU Aixi,LIU Aiping
E-mail:axhu@hnu.edu.cn;llaappliu@sina.cn
Supported by:
摘要:
以2-(4-羟基苯氧)丙酸为原料, 设计合成了16个新的手性N-杂环甲基2-(4-杂芳氧基苯氧基)丙酰胺化合物, 其化学结构经核磁共振、 色谱-质谱、 红外光谱及元素分析确证. 初步生物活性测定结果表明, 合成的化合物在2.25×103 g/ha剂量时对单子叶杂草马唐(Digitaria sanguinalis)、 稗草(Echinochloa crus-galli)及狗尾草(Setaria viridis)等均具有90%以上的活性; 进一步活性及作物安全性测试表明, 化合物(R)-(+)-N-[(6-氯吡啶-3-基)甲基]-2-[4-(3-氯-5-三氟甲基吡啶-2-基氧基)苯氧基]丙酰胺(2b)的除草活性高于噁唑酰草胺, 且对水稻茎叶处理安全, 同时对水稻田主要杂草千金子的活性远高于氰氟草酯; 化合物的除草活性与立体构型有关, R构型为活性构型.
中图分类号:
TrendMD:
刘祈星, 胡艾希, 王晓光, 雷满香, 欧晓明, 任叶果, 黄路, 柳爱平. N-杂环甲基2-(4-杂芳氧基苯氧基)丙酰胺的合成及除草活性. 高等学校化学学报, 2014, 35(2): 262.
LIU Qixing, HU Aixi, WANG Xiaoguang, LEI Manxiang, OU Xiaoming, REN Yeguo, HUANG Lu, LIU Aiping. Synthesis and Herbicidal Activity of N-Arylmethyl-2-(4-arylxoyphenoxy)propionamide†. Chem. J. Chinese Universities, 2014, 35(2): 262.
Compd. | Appearance | Yield*(%) | m.p./℃ | [α (c 1, acetone) | Elemental analysis(%, calcd.) | ||
---|---|---|---|---|---|---|---|
C | H | N | |||||
2a | White solid | 66.7 | 134.4—135.4 | +24.0 | 54.85(55.06) | 3.62(3.70) | 9.72(9.63) |
2b | White solid | 62.5 | 109.6—112.0 | +19.4 | 52.01(51.87) | 3.38(3.32) | 8.56(8.64) |
2c | Pale yellow solid | 57.3 | 78.8—80.1 | +20.2 | 55.60(55.82) | 3.68(3.79) | 9.25(9.30) |
2d | White solid | 77.5 | 130.7—131.3 | +25.4 | 62.25(62.05) | 4.09(4.02) | 9.80(9.87) |
2e | White solid | 68.2 | 143.0—144.1 | +24.9 | 57.63(57.66) | 3.72(3.74) | 9.13(9.17) |
2f | White solid | 53.4 | 171.8—172.5 | +17.4 | 58.81(58.86) | 3.84(3.87) | 11.87(11.94) |
2g | Yellow solid | 25.0 | 100.1—100.9 | +30.4 | 49.01(48.88) | 3.15(3.19) | 9.44(9.50) |
2h | Pale yellow solid | 22.6 | 113.9—115.0 | +25.8 | 46.45(46.35) | 2.91(2.87) | 8.50(8.54) |
2i | Pale yellow oil | 34.1 | +24.9 | 49.88(49.84) | 3.37(3.30) | 9.11(9.18) | |
2j | White solid | 59.7 | 95.2—96.6 | +27.2 | 55.70(55.62) | 3.44(3.50) | 9.70(9.73) |
2k | White solid | 43.9 | 152.5—153.0 | +32.0 | 51.70(51.73) | 3.31(3.26) | 9.10(9.05) |
2l | White solid | 25.9 | 165.2—165.4 | +27.8 | 53.12(53.06) | 3.45(3.39) | 11.88(11.79) |
2m | Pale yellow oil | 48.0 | +19.0 | 49.91(50.01) | 3.49(3.53) | 9.28(9.21) | |
2n | Pale yellow solid | 43.4 | 42.6—54.0 | +7.3 | 47.51(47.44) | 3.23(3.19) | 8.40(8.30) |
2o | Yellow solid | 59.5 | 39.9—40.0 | +10.9 | 51.22(51.07) | 3.82(3.86) | 8.89(8.93) |
2p | Pale yellow oil | 40.5 | +20.0 | 48.65(48.47) | 3.52(3.49) | 8.14(8.08) |
Table 1 Appearance, yields, melting points, optical rotation and elemental analysis for compounds 2a—2p
Compd. | Appearance | Yield*(%) | m.p./℃ | [α (c 1, acetone) | Elemental analysis(%, calcd.) | ||
---|---|---|---|---|---|---|---|
C | H | N | |||||
2a | White solid | 66.7 | 134.4—135.4 | +24.0 | 54.85(55.06) | 3.62(3.70) | 9.72(9.63) |
2b | White solid | 62.5 | 109.6—112.0 | +19.4 | 52.01(51.87) | 3.38(3.32) | 8.56(8.64) |
2c | Pale yellow solid | 57.3 | 78.8—80.1 | +20.2 | 55.60(55.82) | 3.68(3.79) | 9.25(9.30) |
2d | White solid | 77.5 | 130.7—131.3 | +25.4 | 62.25(62.05) | 4.09(4.02) | 9.80(9.87) |
2e | White solid | 68.2 | 143.0—144.1 | +24.9 | 57.63(57.66) | 3.72(3.74) | 9.13(9.17) |
2f | White solid | 53.4 | 171.8—172.5 | +17.4 | 58.81(58.86) | 3.84(3.87) | 11.87(11.94) |
2g | Yellow solid | 25.0 | 100.1—100.9 | +30.4 | 49.01(48.88) | 3.15(3.19) | 9.44(9.50) |
2h | Pale yellow solid | 22.6 | 113.9—115.0 | +25.8 | 46.45(46.35) | 2.91(2.87) | 8.50(8.54) |
2i | Pale yellow oil | 34.1 | +24.9 | 49.88(49.84) | 3.37(3.30) | 9.11(9.18) | |
2j | White solid | 59.7 | 95.2—96.6 | +27.2 | 55.70(55.62) | 3.44(3.50) | 9.70(9.73) |
2k | White solid | 43.9 | 152.5—153.0 | +32.0 | 51.70(51.73) | 3.31(3.26) | 9.10(9.05) |
2l | White solid | 25.9 | 165.2—165.4 | +27.8 | 53.12(53.06) | 3.45(3.39) | 11.88(11.79) |
2m | Pale yellow oil | 48.0 | +19.0 | 49.91(50.01) | 3.49(3.53) | 9.28(9.21) | |
2n | Pale yellow solid | 43.4 | 42.6—54.0 | +7.3 | 47.51(47.44) | 3.23(3.19) | 8.40(8.30) |
2o | Yellow solid | 59.5 | 39.9—40.0 | +10.9 | 51.22(51.07) | 3.82(3.86) | 8.89(8.93) |
2p | Pale yellow oil | 40.5 | +20.0 | 48.65(48.47) | 3.52(3.49) | 8.14(8.08) |
Compd. | 1H NMR(300 MHz, CDCl3), δ | 13C NMR (75 MHz, CDCl3), δ | LC-MS ([M+H]+), m/z | IR(KBr), |
---|---|---|---|---|
2a | 1.61(d, J=6.9 Hz, 3H, CH3), 4.49(d, J=6.6 Hz, 2H, CH2), 4.74(q, J=6.9 Hz, 1H, CH), 6.88—6.94(m, 3H, PhH+NH), 7.08(d, J=9.0 Hz, 2H, PhH), 7.29(d, J=8.1 Hz, 1H, PyH), 7.49—7.53(m, 2H, PyH), 7.87(d, J=2.1 Hz, 1H, PyH), 8.29(d, J=2.4 Hz, 1H, PyH) | 436.0 [M+H]+ | ||
2b | 1.63(d, J=6.6 Hz, 3H, CH3), 4.49(d, J=6.3 Hz, 2H, CH2), 4.73(q, J=6.6 Hz, 1H, CH), 6.88(brs, 1H, NH), 6.96(d, J=9.0 Hz, 2H, PhH), 7.10(d, J=9.0 Hz, 2H, PhH), 7.27(d, J=8.1 Hz, 1H, PyH), 7.51(dd, J=8.1, 2.4 Hz, 1H, PyH), 7.99(d, J=2.4 Hz, 1H, PyH), 8.27—8.30(m, 2H, PyH) | 18.71, 39.65, 75.39, 116.29, 119.15, 122.18, 122.63, 122.93, 124.28, 132.64, 136.31, 138.21, 142.45, 147.17, 148.69, 150.56, 154.25, 161.17, 172.25 | 486.0 [M+H]+ | 3295, 3064, 2985, 1675, 1654, 1613, 1507, 1403, 1391, 1234, 840 |
2c | 1.62(d, J=6.9 Hz, 3H, CH3), 4.49(d, J=6.6 Hz, 2H, CH2), 4.75(q, J=6.9 Hz, 1H, CH), 6.88—7.12(m, 6H, PhH+NH+PyH), 7.30(d, J=8.4 Hz, 1H, PyH), 7.50(dd, J=8.4, 2.4 Hz, 1H, PyH), 7.90(dd, J=8.7, 2.4 Hz, 1H, PyH), 8.27(d, J=2.4 Hz, 1H, PyH), 8.42—8.44(m, 1H, PyH) | 451.9 [M+H]+ | ||
2d | 1.60(d, J=6.9 Hz, 3H, CH3), 4.40—4.58(m, 2H, CH2), 4.74(q, J=6.9 Hz, 1H, CH), 6.87—7.04(m, 6H, 4PhH+NH+PyH), 7.04(d, J=6.6 Hz, 1H, PyH), 7.27(d, J=6.3 Hz, 1H, PyH), 7.37—7.56(m, 3H, PhH), 8.22(d, J=1.8 Hz, 1H, PyH) | 426.1 [M+H]+ | ||
2e | 1.60(d, J=6.9 Hz, 3H, CH3), 4.47—4.50(m, 2H, CH2), 4.76(q, J=6.9 Hz, 1H, CH), 6.86—6.99(m, 3H, 2PhH+NH), 7.24—7.54(m, 8H, PyH+benzoxazole-H+PhH) | 458.0 [M+H]+ | ||
2f | 1.62(d, J=6.9 Hz, 3H, CH3), 4.50(s, 2H, CH2), 4.76(q, J=6.9 Hz, 1H, CH), 6.92—6.98(m, 3H, 2PhH+NH), 7.19(d, J=9.0 Hz, 2H, PhH), 7.30(d, J=8.1 Hz, 1H, PyH), 7.52(d, J=8.1 Hz, 1H, PyH), 7.62(dd, J=8.7, 2.7 Hz, 1H, quinoxalin-H), 7.66(d, J=8.7 Hz, 1H, quinoxalin-H), 8.06(d, J=2.7 Hz, 1H, quinoxalin-H), 8.30(s, 1H, PyH), 8.69(s, 1H, quinoxalin-H) | 18.74, 39.72, 75.42, 116.29, 122.76, 124.30, 127.93, 128.71, 131.18, 132.64, 132.91, 138.21, 138.36, 139.76, 140.06, 146.95, 148.73, 150.62, 154.05, 157.00, 172.27 | 469.0 [M+H]+ | |
2g | 1.58(d, J=6.9 Hz, 3H, CH3), 4.57(t, J=6.3 Hz, 2H, CH2), 4.69(q, J=6.9 Hz, 1H, CH), 6.90—6.93(m, 3H, PhH+NH), 7.11(d, J=9.3 Hz, 2H, PhH), 7.38(s, 1H, Thia-H), 7.50(dd, J=9.0, 2.1 Hz, 1H, PyH), 7.87(d, J=2.1 Hz, 1H, PyH) | 18.55, 35.44, 75.31, 116.31, 122.50, 124.85, 125.08, 139.36, 140.09, 145.08, 147.37, 148.62, 151.15, 152.10, 153.85, 172.20 | 442.0 [M+H]+ | |
2h | 1.59(d, J=6.9 Hz, 3H, CH3), 4.56—4.59(m, 2H, CH2), 4.71(q, J=6.9 Hz, 1H, CH), 6.92—6.97(m, 3H, PhH+NH), 7.09(d, J=9.0 Hz, 2H, PhH), 7.38(s, 1H, Thia-H), 7.99(d, J=2.1 Hz, 1H, PyH), 8.26(s, 1H, PyH) | 492.0 [M+H]+ | ||
2i | 1.61(d, J=6.9 Hz, 3H, CH3), 4.56—4.59(m, 2H, CH2), 4.72(q, J=6.9 Hz, 1H, CH), 6.90—6.95(m, 3H, PhH+NH), 7.03(d, J=8.7 Hz, 1H, PyH), 7.07(d, J=9.0 Hz, 2H, PhH), 7.37(s, 1H, Thia—H), 7.92(dd, J=8.7, 2.4 Hz, 1H, PyH), 8.42—8.43(m, 1H, PyH) | 457.8 [M+H]+ | ||
2j | 1.60(d, J=6.6 Hz, 3H, CH3), 4.40—4.58(m, 2H, CH2), 4.69(q, J=6.6 Hz, 1H, CH), 6.86—6.93(m, 3H, 2PhH+NH), 7.00(d, J=9.3 Hz, 2H, PhH), 7.27(s, 1H, Thia-H), 7.35—7.49(m, 3H, PhH) | 432.0 [M+H]+ | ||
2k | 1.61(d, J=6.6 Hz, 3H, CH3), 4.54—4.60(m, 2H, CH2), 4.73(q, J=6.6 Hz, 1H, CH), 6.92—6.98(m, 3H, 2PhH+NH), 7.23—7.45(m, 6H, Thia-H+benzoxazole-H+2PhH) | 464.0 [M+H]+ | ||
2l | 1.63(d, J=6.9 Hz, 3H, CH3), 4.59(d, J=6.0 Hz, 2H, CH2), 4.76(q, J=6.9 Hz, 1H, CH), 6.930—6.98(m, 3H, 2PhH+NH), 7.20(d, J=9.0 Hz, 2H, PhH), 7.39(s, 1H, Thia-H), 7.59(dd, J1=8.7 Hz, J2=2.1 Hz, 1H, quinoxalin-H), 7.67(d, J=8.7 Hz, 1H, quinoxalin-H), 8.07(d, J=2.1 Hz, 1H, quinoxalin-H), 8.69(s, 1H, quinoxalin-H) | 18.57, 35.49, 75.33, 116.29, 122.70, 127.87, 128.68, 131.10, 132.85, 137.56, 138.33, 139.36, 139.70, 140.00, 146.93, 152.12, 153.99, 156.96, 172.20 | 475.0 [M+H]+ | 3345, 1655, 1608, 1580, 1535, 1505, 1420, 1239, 822 |
2m | 1.59(d, J=6.9 Hz, 3H, CH3), 3.12(s, 3H, CH3), 4.51(dd, J=15, 40.2 Hz, 2H, CH2), 4.93(q, J=6.9 Hz, 1H, CH), 6.92(d, J=9.0 Hz, 2H, PhH), 7.09(d, J=9.0 Hz, 2H, PhH), 7.41(s, 1H, Thia-H), 7.49(dd, J=9.0, 2.4 Hz, 1H, PyH), 7.87(d, J=2.4 Hz, 1H, PyH) | 456.0 [M+H]+ | ||
2n | 1.61(d, J=6.6 Hz, 3H, CH3), 3.13(s, 3H, CH3), 4.53(dd, J=15, 33 Hz, 2H, CH2), 4.97(q, J=6.6 Hz, 1H, CH), 6.94(d, J=9.0 Hz, 2H, PhH), 7.07(d, J=9.0 Hz, 2H, PhH), 7.41(s, 1H, Thia-H), 7.98(d, J=2.4 Hz, 1H, PyH), 7.27(s, 1H, PyH) | 506.0 [M+H]+ | ||
2o | 1.10(t, J=7.2 Hz, 3H, CH3), 1.53(d, J=6.6 Hz, 3H, CH3), 3.38—3.49(m, 2H, CH2), 4.48(m, 2H, CH2), 4.88(q, J=6.6 Hz, 1H, CH), 6.84(d, J=9.3 Hz, 2H, PhH), 6.97(d, J=9.3 Hz, 2H, PhH), 7.33(s, 1H, Thia-H), 7.40(dd, J=9.0, 2.4 Hz, 1H, PyH), 7.78(d, J=2.4 Hz, 1H, PyH) | 470.0 [M+H]+ | ||
2p | 1.18(t, J=7.2 Hz, 3H, CH3), 1.58(d, J=6.9 Hz, 3H, CH3), 3.36—3.64(m, 2H, CH2), 4.55(dd, J=15, 20.4 Hz, 2H, CH2), 4.95(q, J=6.9 Hz, 1H, CH), 6.95(d, J=9.0 Hz, 2H, PhH), 7.10(d, J=9.0 Hz, 2H, PhH), 7.41(s, 1H, Thia-H), 7.98(d, J=2.1 Hz,, 1H, PyH), 8.27(s, 1H, PyH) | 520.0 [M+H]+ |
Table 2 1H NMR, 13C NMR, LC-MS and IR data for compounds 2a—2p
Compd. | 1H NMR(300 MHz, CDCl3), δ | 13C NMR (75 MHz, CDCl3), δ | LC-MS ([M+H]+), m/z | IR(KBr), |
---|---|---|---|---|
2a | 1.61(d, J=6.9 Hz, 3H, CH3), 4.49(d, J=6.6 Hz, 2H, CH2), 4.74(q, J=6.9 Hz, 1H, CH), 6.88—6.94(m, 3H, PhH+NH), 7.08(d, J=9.0 Hz, 2H, PhH), 7.29(d, J=8.1 Hz, 1H, PyH), 7.49—7.53(m, 2H, PyH), 7.87(d, J=2.1 Hz, 1H, PyH), 8.29(d, J=2.4 Hz, 1H, PyH) | 436.0 [M+H]+ | ||
2b | 1.63(d, J=6.6 Hz, 3H, CH3), 4.49(d, J=6.3 Hz, 2H, CH2), 4.73(q, J=6.6 Hz, 1H, CH), 6.88(brs, 1H, NH), 6.96(d, J=9.0 Hz, 2H, PhH), 7.10(d, J=9.0 Hz, 2H, PhH), 7.27(d, J=8.1 Hz, 1H, PyH), 7.51(dd, J=8.1, 2.4 Hz, 1H, PyH), 7.99(d, J=2.4 Hz, 1H, PyH), 8.27—8.30(m, 2H, PyH) | 18.71, 39.65, 75.39, 116.29, 119.15, 122.18, 122.63, 122.93, 124.28, 132.64, 136.31, 138.21, 142.45, 147.17, 148.69, 150.56, 154.25, 161.17, 172.25 | 486.0 [M+H]+ | 3295, 3064, 2985, 1675, 1654, 1613, 1507, 1403, 1391, 1234, 840 |
2c | 1.62(d, J=6.9 Hz, 3H, CH3), 4.49(d, J=6.6 Hz, 2H, CH2), 4.75(q, J=6.9 Hz, 1H, CH), 6.88—7.12(m, 6H, PhH+NH+PyH), 7.30(d, J=8.4 Hz, 1H, PyH), 7.50(dd, J=8.4, 2.4 Hz, 1H, PyH), 7.90(dd, J=8.7, 2.4 Hz, 1H, PyH), 8.27(d, J=2.4 Hz, 1H, PyH), 8.42—8.44(m, 1H, PyH) | 451.9 [M+H]+ | ||
2d | 1.60(d, J=6.9 Hz, 3H, CH3), 4.40—4.58(m, 2H, CH2), 4.74(q, J=6.9 Hz, 1H, CH), 6.87—7.04(m, 6H, 4PhH+NH+PyH), 7.04(d, J=6.6 Hz, 1H, PyH), 7.27(d, J=6.3 Hz, 1H, PyH), 7.37—7.56(m, 3H, PhH), 8.22(d, J=1.8 Hz, 1H, PyH) | 426.1 [M+H]+ | ||
2e | 1.60(d, J=6.9 Hz, 3H, CH3), 4.47—4.50(m, 2H, CH2), 4.76(q, J=6.9 Hz, 1H, CH), 6.86—6.99(m, 3H, 2PhH+NH), 7.24—7.54(m, 8H, PyH+benzoxazole-H+PhH) | 458.0 [M+H]+ | ||
2f | 1.62(d, J=6.9 Hz, 3H, CH3), 4.50(s, 2H, CH2), 4.76(q, J=6.9 Hz, 1H, CH), 6.92—6.98(m, 3H, 2PhH+NH), 7.19(d, J=9.0 Hz, 2H, PhH), 7.30(d, J=8.1 Hz, 1H, PyH), 7.52(d, J=8.1 Hz, 1H, PyH), 7.62(dd, J=8.7, 2.7 Hz, 1H, quinoxalin-H), 7.66(d, J=8.7 Hz, 1H, quinoxalin-H), 8.06(d, J=2.7 Hz, 1H, quinoxalin-H), 8.30(s, 1H, PyH), 8.69(s, 1H, quinoxalin-H) | 18.74, 39.72, 75.42, 116.29, 122.76, 124.30, 127.93, 128.71, 131.18, 132.64, 132.91, 138.21, 138.36, 139.76, 140.06, 146.95, 148.73, 150.62, 154.05, 157.00, 172.27 | 469.0 [M+H]+ | |
2g | 1.58(d, J=6.9 Hz, 3H, CH3), 4.57(t, J=6.3 Hz, 2H, CH2), 4.69(q, J=6.9 Hz, 1H, CH), 6.90—6.93(m, 3H, PhH+NH), 7.11(d, J=9.3 Hz, 2H, PhH), 7.38(s, 1H, Thia-H), 7.50(dd, J=9.0, 2.1 Hz, 1H, PyH), 7.87(d, J=2.1 Hz, 1H, PyH) | 18.55, 35.44, 75.31, 116.31, 122.50, 124.85, 125.08, 139.36, 140.09, 145.08, 147.37, 148.62, 151.15, 152.10, 153.85, 172.20 | 442.0 [M+H]+ | |
2h | 1.59(d, J=6.9 Hz, 3H, CH3), 4.56—4.59(m, 2H, CH2), 4.71(q, J=6.9 Hz, 1H, CH), 6.92—6.97(m, 3H, PhH+NH), 7.09(d, J=9.0 Hz, 2H, PhH), 7.38(s, 1H, Thia-H), 7.99(d, J=2.1 Hz, 1H, PyH), 8.26(s, 1H, PyH) | 492.0 [M+H]+ | ||
2i | 1.61(d, J=6.9 Hz, 3H, CH3), 4.56—4.59(m, 2H, CH2), 4.72(q, J=6.9 Hz, 1H, CH), 6.90—6.95(m, 3H, PhH+NH), 7.03(d, J=8.7 Hz, 1H, PyH), 7.07(d, J=9.0 Hz, 2H, PhH), 7.37(s, 1H, Thia—H), 7.92(dd, J=8.7, 2.4 Hz, 1H, PyH), 8.42—8.43(m, 1H, PyH) | 457.8 [M+H]+ | ||
2j | 1.60(d, J=6.6 Hz, 3H, CH3), 4.40—4.58(m, 2H, CH2), 4.69(q, J=6.6 Hz, 1H, CH), 6.86—6.93(m, 3H, 2PhH+NH), 7.00(d, J=9.3 Hz, 2H, PhH), 7.27(s, 1H, Thia-H), 7.35—7.49(m, 3H, PhH) | 432.0 [M+H]+ | ||
2k | 1.61(d, J=6.6 Hz, 3H, CH3), 4.54—4.60(m, 2H, CH2), 4.73(q, J=6.6 Hz, 1H, CH), 6.92—6.98(m, 3H, 2PhH+NH), 7.23—7.45(m, 6H, Thia-H+benzoxazole-H+2PhH) | 464.0 [M+H]+ | ||
2l | 1.63(d, J=6.9 Hz, 3H, CH3), 4.59(d, J=6.0 Hz, 2H, CH2), 4.76(q, J=6.9 Hz, 1H, CH), 6.930—6.98(m, 3H, 2PhH+NH), 7.20(d, J=9.0 Hz, 2H, PhH), 7.39(s, 1H, Thia-H), 7.59(dd, J1=8.7 Hz, J2=2.1 Hz, 1H, quinoxalin-H), 7.67(d, J=8.7 Hz, 1H, quinoxalin-H), 8.07(d, J=2.1 Hz, 1H, quinoxalin-H), 8.69(s, 1H, quinoxalin-H) | 18.57, 35.49, 75.33, 116.29, 122.70, 127.87, 128.68, 131.10, 132.85, 137.56, 138.33, 139.36, 139.70, 140.00, 146.93, 152.12, 153.99, 156.96, 172.20 | 475.0 [M+H]+ | 3345, 1655, 1608, 1580, 1535, 1505, 1420, 1239, 822 |
2m | 1.59(d, J=6.9 Hz, 3H, CH3), 3.12(s, 3H, CH3), 4.51(dd, J=15, 40.2 Hz, 2H, CH2), 4.93(q, J=6.9 Hz, 1H, CH), 6.92(d, J=9.0 Hz, 2H, PhH), 7.09(d, J=9.0 Hz, 2H, PhH), 7.41(s, 1H, Thia-H), 7.49(dd, J=9.0, 2.4 Hz, 1H, PyH), 7.87(d, J=2.4 Hz, 1H, PyH) | 456.0 [M+H]+ | ||
2n | 1.61(d, J=6.6 Hz, 3H, CH3), 3.13(s, 3H, CH3), 4.53(dd, J=15, 33 Hz, 2H, CH2), 4.97(q, J=6.6 Hz, 1H, CH), 6.94(d, J=9.0 Hz, 2H, PhH), 7.07(d, J=9.0 Hz, 2H, PhH), 7.41(s, 1H, Thia-H), 7.98(d, J=2.4 Hz, 1H, PyH), 7.27(s, 1H, PyH) | 506.0 [M+H]+ | ||
2o | 1.10(t, J=7.2 Hz, 3H, CH3), 1.53(d, J=6.6 Hz, 3H, CH3), 3.38—3.49(m, 2H, CH2), 4.48(m, 2H, CH2), 4.88(q, J=6.6 Hz, 1H, CH), 6.84(d, J=9.3 Hz, 2H, PhH), 6.97(d, J=9.3 Hz, 2H, PhH), 7.33(s, 1H, Thia-H), 7.40(dd, J=9.0, 2.4 Hz, 1H, PyH), 7.78(d, J=2.4 Hz, 1H, PyH) | 470.0 [M+H]+ | ||
2p | 1.18(t, J=7.2 Hz, 3H, CH3), 1.58(d, J=6.9 Hz, 3H, CH3), 3.36—3.64(m, 2H, CH2), 4.55(dd, J=15, 20.4 Hz, 2H, CH2), 4.95(q, J=6.9 Hz, 1H, CH), 6.95(d, J=9.0 Hz, 2H, PhH), 7.10(d, J=9.0 Hz, 2H, PhH), 7.41(s, 1H, Thia-H), 7.98(d, J=2.1 Hz,, 1H, PyH), 8.27(s, 1H, PyH) | 520.0 [M+H]+ |
Compd. | Postemergence treatment | Preemergence treatment | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A.T. | A.A. | C.A. | D.S. | E.C. | S.V. | A.T. | A.A. | C.A. | D.S. | E.C. | S.V. | ||
2a | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 | 100 | 100 | 100 | |
2b | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 | 100 | 100 | 100 | |
2c | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 | 100 | 100 | 100 | |
2d | 0 | 0 | 0 | 90 | 90 | 90 | 0 | 0 | 0 | 90 | 90 | 90 | |
2e | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 | 100 | 95 | 95 | |
2f | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 | 100 | 100 | 100 | |
2g | 0 | 0 | 0 | 100 | 90 | 100 | 0 | 0 | 0 | 100 | 100 | 100 | |
2h | 0 | 0 | 0 | 100 | 100 | 95 | 0 | 0 | 0 | 100 | 100 | 100 | |
2i | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 | 100 | 98 | 100 | |
2j | 0 | 0 | 0 | 90 | 90 | 90 | 0 | 0 | 0 | 90 | 90 | 90 | |
2k | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 | 100 | 100 | 90 | |
2l | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 | 100 | 100 | 100 | |
2m | 0 | 0 | 0 | 60 | 40 | 50 | 0 | 0 | 0 | 100 | 50 | 100 | |
2n | 0 | 0 | 0 | 90 | 30 | 80 | 0 | 0 | 0 | 90 | 90 | 90 | |
2o | 0 | 0 | 0 | 90 | 80 | 85 | 0 | 0 | 0 | 100 | 100 | 100 | |
2p | 0 | 0 | 0 | 100 | 100 | 90 | 0 | 0 | 0 | 100 | 100 | 100 | |
Metamifop | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 | 100 | 100 | 100 | |
Clodinafop-propargyl | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 | 100 | 100 | 100 |
Table 3 Herbicidal activities of compounds 2a—2p at dosage of 2.25×103 g/ha*
Compd. | Postemergence treatment | Preemergence treatment | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A.T. | A.A. | C.A. | D.S. | E.C. | S.V. | A.T. | A.A. | C.A. | D.S. | E.C. | S.V. | ||
2a | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 | 100 | 100 | 100 | |
2b | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 | 100 | 100 | 100 | |
2c | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 | 100 | 100 | 100 | |
2d | 0 | 0 | 0 | 90 | 90 | 90 | 0 | 0 | 0 | 90 | 90 | 90 | |
2e | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 | 100 | 95 | 95 | |
2f | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 | 100 | 100 | 100 | |
2g | 0 | 0 | 0 | 100 | 90 | 100 | 0 | 0 | 0 | 100 | 100 | 100 | |
2h | 0 | 0 | 0 | 100 | 100 | 95 | 0 | 0 | 0 | 100 | 100 | 100 | |
2i | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 | 100 | 98 | 100 | |
2j | 0 | 0 | 0 | 90 | 90 | 90 | 0 | 0 | 0 | 90 | 90 | 90 | |
2k | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 | 100 | 100 | 90 | |
2l | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 | 100 | 100 | 100 | |
2m | 0 | 0 | 0 | 60 | 40 | 50 | 0 | 0 | 0 | 100 | 50 | 100 | |
2n | 0 | 0 | 0 | 90 | 30 | 80 | 0 | 0 | 0 | 90 | 90 | 90 | |
2o | 0 | 0 | 0 | 90 | 80 | 85 | 0 | 0 | 0 | 100 | 100 | 100 | |
2p | 0 | 0 | 0 | 100 | 100 | 90 | 0 | 0 | 0 | 100 | 100 | 100 | |
Metamifop | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 | 100 | 100 | 100 | |
Clodinafop-propargyl | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 | 100 | 100 | 100 |
Compd. | Postemergence treatment | Preemergence treatment | Compd. | Postemergence treatment | Preemergence treatment | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D.S. | E.C. | S.V. | D.S. | E.C. | S.V. | D.S. | E.C. | S.V. | D.S. | E.C. | S.V. | ||
2a | 90 | 100 | 100 | 70 | 40 | 80 | 2j | 30 | 30 | 30 | 0 | 0 | 0 |
2b | 100 | 100 | 100 | 100 | 100 | 100 | 2k | 90 | 80 | 90 | 0 | 0 | 0 |
2c | 90 | 85 | 85 | 70 | 60 | 70 | 2l | 90 | 85 | 100 | 90 | 90 | 90 |
2d | 30 | 30 | 30 | 0 | 0 | 0 | 2m | 0 | 0 | 0 | 0 | 0 | 0 |
2e | 90 | 50 | 90 | 0 | 0 | 0 | 2n | 0 | 0 | 0 | 50 | 0 | 0 |
2f | 90 | 50 | 100 | 30 | 30 | 0 | 2o | 0 | 0 | 0 | 0 | 0 | 0 |
2g | 100 | 100 | 100 | 100 | 100 | 100 | 2p | 50 | 40 | 50 | 70 | 40 | 70 |
2h | 95 | 95 | 95 | 100 | 100 | 100 | Metamifop | 95 | 80 | 80 | 0 | 0 | 0 |
2i | 100 | 100 | 100 | 50 | 0 | 0 | Clodinafop- | 100 | 100 | 100 | 100 | 100 | 100 |
propargyl |
Table 4 Preliminary herbicidal activities at dosage of 75 g/ha
Compd. | Postemergence treatment | Preemergence treatment | Compd. | Postemergence treatment | Preemergence treatment | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D.S. | E.C. | S.V. | D.S. | E.C. | S.V. | D.S. | E.C. | S.V. | D.S. | E.C. | S.V. | ||
2a | 90 | 100 | 100 | 70 | 40 | 80 | 2j | 30 | 30 | 30 | 0 | 0 | 0 |
2b | 100 | 100 | 100 | 100 | 100 | 100 | 2k | 90 | 80 | 90 | 0 | 0 | 0 |
2c | 90 | 85 | 85 | 70 | 60 | 70 | 2l | 90 | 85 | 100 | 90 | 90 | 90 |
2d | 30 | 30 | 30 | 0 | 0 | 0 | 2m | 0 | 0 | 0 | 0 | 0 | 0 |
2e | 90 | 50 | 90 | 0 | 0 | 0 | 2n | 0 | 0 | 0 | 50 | 0 | 0 |
2f | 90 | 50 | 100 | 30 | 30 | 0 | 2o | 0 | 0 | 0 | 0 | 0 | 0 |
2g | 100 | 100 | 100 | 100 | 100 | 100 | 2p | 50 | 40 | 50 | 70 | 40 | 70 |
2h | 95 | 95 | 95 | 100 | 100 | 100 | Metamifop | 95 | 80 | 80 | 0 | 0 | 0 |
2i | 100 | 100 | 100 | 50 | 0 | 0 | Clodinafop- | 100 | 100 | 100 | 100 | 100 | 100 |
propargyl |
Compd. | D.S./(g·ha-1) | E.C./(g·ha-1) | I | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
30 | 15 | 7.5 | 3.75 | 30 | 15 | 7.5 | 3.75 | D.S. | E.C. | |||
2b | 70 | 50 | 30 | 10 | 70 | 30 | 0 | 0 | 15.4 | 22.8 | ||
2g | 40 | 30 | 20 | 10 | 50 | 30 | 20 | 10 | 46.5 | 21.8 | ||
2h | 50 | 40 | 30 | 10 | 50 | 30 | 0 | 0 | 25.2 | 25.0 | ||
Metamifop | 50 | 30 | 20 | 10 | 50 | 30 | 0 | 0 | 31.9 | 25.0 | ||
Clodinafop-propargyl | 40 | 30 | 20 | 10 | 70 | 50 | 30 | 20 | 46.5 | 14.6 |
Table 5 Further herbicidal activities and IC50 values against D.S. and E.C. in postemergence treatments
Compd. | D.S./(g·ha-1) | E.C./(g·ha-1) | I | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
30 | 15 | 7.5 | 3.75 | 30 | 15 | 7.5 | 3.75 | D.S. | E.C. | |||
2b | 70 | 50 | 30 | 10 | 70 | 30 | 0 | 0 | 15.4 | 22.8 | ||
2g | 40 | 30 | 20 | 10 | 50 | 30 | 20 | 10 | 46.5 | 21.8 | ||
2h | 50 | 40 | 30 | 10 | 50 | 30 | 0 | 0 | 25.2 | 25.0 | ||
Metamifop | 50 | 30 | 20 | 10 | 50 | 30 | 0 | 0 | 31.9 | 25.0 | ||
Clodinafop-propargyl | 40 | 30 | 20 | 10 | 70 | 50 | 30 | 20 | 46.5 | 14.6 |
Compd. | Dosage/(g·ha-1) | Postemergence treatment | IC50(g·ha-1) | ||||
---|---|---|---|---|---|---|---|
D.S. | E.C. | S.V. | D.S. | E.C. | S.V. | ||
2b | 3.75 | 40 | 0 | 20 | 5.2 | 13.9 | 6.5 |
7.5 | 60 | 10 | 50 | (3.1—8.8) | (11.1—17.5) | (3.9—11.0) | |
15 | 95 | 80 | 80 | ||||
30 | 100 | 95 | 100 | ||||
60 | 100 | 100 | 100 | ||||
(±)-2b | 3.75 | 40 | 0 | 20 | 6.4 | 28.0 | 10.1 |
7.5 | 50 | 0 | 40 | (4.9—8.5) | (18.7—42.0) | (7.2—14.1) | |
15 | 70 | 30 | 50 | ||||
30 | 90 | 50 | 90 | ||||
60 | 98 | 98 | 90 |
Table 6 Comparative herbicidal activities of compounds 2b and(±)-2b
Compd. | Dosage/(g·ha-1) | Postemergence treatment | IC50(g·ha-1) | ||||
---|---|---|---|---|---|---|---|
D.S. | E.C. | S.V. | D.S. | E.C. | S.V. | ||
2b | 3.75 | 40 | 0 | 20 | 5.2 | 13.9 | 6.5 |
7.5 | 60 | 10 | 50 | (3.1—8.8) | (11.1—17.5) | (3.9—11.0) | |
15 | 95 | 80 | 80 | ||||
30 | 100 | 95 | 100 | ||||
60 | 100 | 100 | 100 | ||||
(±)-2b | 3.75 | 40 | 0 | 20 | 6.4 | 28.0 | 10.1 |
7.5 | 50 | 0 | 40 | (4.9—8.5) | (18.7—42.0) | (7.2—14.1) | |
15 | 70 | 30 | 50 | ||||
30 | 90 | 50 | 90 | ||||
60 | 98 | 98 | 90 |
Compd. | Dosage/ (g·ha-1) | Xiang zao xian 24 | Dosage/ (g·ha-1) | E. C. | Leptochloa |
---|---|---|---|---|---|
2b | 15 | 3.79 | 3.75 | 3.20 | 50 |
30 | 7.21 | 7.5 | 76.38 | 90 | |
60 | 13.77 | 15 | 89.74 | 98 | |
120 | 27.43 | 30 | 94.65 | 100 | |
240 | 63.52 | 60 | 100.00 | 100 | |
Metamifop | 15 | -45.04 | 3.75 | 24.18 | |
30 | -15.34 | 7.5 | 37.10 | ||
60 | -57.94 | 15 | 49.39 | ||
120 | -14.58 | 30 | 99.00 | ||
240 | -34.15 | 60 | 100.00 | ||
Cyhalofop-butyl | 15 | -11.38 | 3.75 | 35.02 | 0 |
30 | -9.00 | 7.5 | 41.10 | 0 | |
60 | -9.38 | 15 | 47.97 | 0 | |
120 | -10.73 | 30 | 55.02 | 30 | |
240 | 8.78 | 60 | 64.14 | 50 |
Table 7 Phytotoxicit of compound 2b to Xiang zao xian 24 in postemergence treatments*
Compd. | Dosage/ (g·ha-1) | Xiang zao xian 24 | Dosage/ (g·ha-1) | E. C. | Leptochloa |
---|---|---|---|---|---|
2b | 15 | 3.79 | 3.75 | 3.20 | 50 |
30 | 7.21 | 7.5 | 76.38 | 90 | |
60 | 13.77 | 15 | 89.74 | 98 | |
120 | 27.43 | 30 | 94.65 | 100 | |
240 | 63.52 | 60 | 100.00 | 100 | |
Metamifop | 15 | -45.04 | 3.75 | 24.18 | |
30 | -15.34 | 7.5 | 37.10 | ||
60 | -57.94 | 15 | 49.39 | ||
120 | -14.58 | 30 | 99.00 | ||
240 | -34.15 | 60 | 100.00 | ||
Cyhalofop-butyl | 15 | -11.38 | 3.75 | 35.02 | 0 |
30 | -9.00 | 7.5 | 41.10 | 0 | |
60 | -9.38 | 15 | 47.97 | 0 | |
120 | -10.73 | 30 | 55.02 | 30 | |
240 | 8.78 | 60 | 64.14 | 50 |
[1] | Becker W., Langelueddeke P., Leditschke H., Herbicidal α-(4-Phenoxyphenoxy) Alkanecarboxylic Acid Derivatives DE2223894A, 1973-12-13 |
[2] | James A. T., Daniel J. P., J. Agric. Food Chem., 2002, 50(16), 4554—4566 |
[3] | Schurter R., Rempfler H., 2-{4-[(5-Chloro-3-fluoropyridin-2-yl)oxy]phenoxy}propionic Acid Propynyl Ester with Herbicidal Activity, US 4713109A, 1987-12-15 |
[4] | Ruiz-SantaellaJ. P., Heredia A., de Prado R., Planta, 2006, 223(2), 191—199 |
[5] | Moon J. K., Keum Y. S., Hwang E. C., J. Agric. Food Chem., 2007, 55(14), 5416—5422 |
[6] | Rahman M. M., Ismail B. S., Abdul S. J., Aust. J. Crop Sci., 2010, 4(2), 106—114 |
[7] | Im S. H., Park M. W., Yook M. J., Kim D. S., Korean J. Weed Sci., 2009, 29(2), 178—184 |
[8] | Wang Q. M., Li H., Li Y. H., Huang R. Q., J. Agric. Food Chem., 2004, 52(7), 1918—1922 |
[9] | Li G. Y., Qian X. H., Cui J. G., Huang Q. C., Zhang R., Guan H., J. Agric. Food Chem., 2006, 54(1), 125—129 |
[10] | Dai H., Li Y. Q., Du D., Qin X., Zhang X., Yu H. B., Fang J. X., J. Agric. Food Chem., 2008, 56(22), 10805—10810 |
[11] | Luo X. F., Hu A. X., Wang Y., Ye J., Wang X. G., Ou X. M., Chem. J. Chinese Universities, 2011, 32(12), 2800—2805 |
(罗先福, 胡艾希, 王宇, 叶姣, 王晓光, 欧晓明.高等学校化学学报,2011, 32(12), 2800—2805) | |
[12] | Yan M., Shi D. Q., Xiao L. X., Chin. J. Org. Chem., 2008, 28(6), 1012—1015 |
(严曼, 石德清, 肖琳霞.有机化学,2008, 28(6), 1012—1015) | |
[13] | Xiao L. X., Shi D. Q., Chin. J. Org. Chem., 2010, 30(1), 85—91 |
(肖琳霞, 石德清.有机化学,2010, 30(1), 85—91) | |
[14] | Yu Z. H., Shi D. Q., J. Huazhong Norm. University(Nat. Sci.), 2011, 45(2), 249—253 |
(余治华, 石德清. 华中师范大学学报(自然科学版), 2011, 45(2), 249—253) | |
[15] | Zhou Y. Y., Li Y. X., Li Y. M., Yang X. P., Mao M. Z., Li Z. M., Chem. Res. Chinese Universities, 2013, 29(2), 249—255 |
[16] | Yan T., Yu G. P., Liu P. F., Xiong L. X., Yu S. J., Li Z. M., Chem. Res. Chinese Universities, 2012, 28(1), 53—56 |
[17] | Liu A. P., Cheng S. X., Lei M. X., Yao Y., Hu Z. B., He H. J., Wu Y. Y., Xiang J., Liu M. H., Preparation of N-oxo-Aryloxyphenoxycarboxylic Acid Amide Compounds with Herbicidal and Insecticidal Biological Activities CN101885703A, 2010-11-17 |
(柳爱平, 成四喜, 雷满香, 姚远, 胡志彬, 何海军, 伍茵茵, 项军, 刘民华. 具有生物活性的N-氧基芳氧苯氧羧酸酰胺类化合物及其制备方法, CN101885703A, 2010-11-17) | |
[18] | Yi K. H., Fu Y., Ye F., Plant Protection, 2012, 38(1), 11—17 |
(衣克寒, 付颖, 叶非.植物保护,2012, 38(1), 11—17) | |
[19] | Liu Y. X., Wei D. G., Zhu Y. R., Liu S. H., Zhang Y. L., Zhao Q. Q., Cai B. L., Li Y. H., Song H. B., Liu Y., Wang Y., Huang R. Q., Wang Q. M., J. Agri. Food Chem., 2008, 56(1), 204—212 |
[20] | Kong F. L., Ma Y. G., Wu G. X., Preparation of Nicotine Compounds as Insecticides, CN102633740A, 2012-8-15 |
(孔繁蕾, 马英高, 吴桂秀. 新烟碱类化合物及其制备方法和应用, CN102633740A, 2012-08-15) | |
[21] | Yuan H. L., Liu W. D., Lan Z. L., Du S. H., Fine Chemical Intermediates, 2011, 41(2), 24—27 |
(袁海龙, 刘卫东, 兰支利, 杜升华.精细化工中间体,2011, 41(2), 24—27) | |
[22] | Fan Z. P., Hua Z., Frank V., Process for the Preparation of Substituted Tetralin and Substituted Indane Derivatives US20050240049A, 2005-10-27 |
[23] | Huang M. Z., Huang K. L., Ren Y. G., Lei M. X., Huang L., Hou Z. K., Liu A. P., Ou X. M., J. Agri. Food Chem., 2005, 53(20), 7908—7914 |
[24] | Qin Y. H., J. Ningbo University(Nat. Sci.), 2007, 20(3), 381—384 |
(秦永华. 宁波大学学报(理工版), 2007, 20(3), 381—384) |
[1] | 杨子辉, 李贝贝, 叶姣, 胡艾希. 基于呋喃酚构建2-(4-芳氧苯氧基)丙酰胺及除草活性[J]. 高等学校化学学报, 2016, 37(8): 1442. |
[2] | 陈伟, 魏巍, 刘明, 华学文, 李玉新, 李永红, 张晓, 李正名. 新型含二甲氧基甲基嘧啶基磺酰脲衍生物的合成及生物活性[J]. 高等学校化学学报, 2015, 36(7): 1291. |
[3] | 陈伟, 魏巍, 李玉新, 万莹莹, 刘巧霞, 李永红, 于淑晶, 李正名. 2-甲基-6-硝基苯磺酰脲衍生物的合成及生物活性[J]. 高等学校化学学报, 2015, 36(5): 907. |
[4] | 陈伟, 魏巍, 周莎, 李永红, 张晓, 童军, 李玉新, 李正名. 新型含苯基取代嘧啶基磺酰脲衍生物的设计、 合成及生物活性[J]. 高等学校化学学报, 2015, 36(4): 672. |
[5] | 潘里, 刘卓, 陈有为, 李永红, 李正名. 含有单取代嘧啶的新型磺酰脲类化合物的设计、合成及除草活性[J]. 高等学校化学学报, 2013, 34(6): 1416. |
[6] | 李洋, 张志国, 迟会伟, 罗艳梅, 刘长令, 李正名. 2-酰基-氰基乙酸衍生物的合成及生物活性[J]. 高等学校化学学报, 2010, 31(9): 1798. |
[7] | 李文明, 王建国, 李永红, 王素华, 李正名. 新型取代苯甲酰胺类化合物的合成及对 AHAS酶的抑制和除草活性[J]. 高等学校化学学报, 2010, 31(8): 1574. |
[8] | 王婷婷, 邴贵芳, 张欣, 秦振芳, 于海波, 秦雪, 戴红, 方建新. 3-(5′-乙氧基-1,3,4-噻二唑-2′-亚甲氨基)-2-氰基-3-取代-丙烯酸酯类化合物的合成、晶体结构及生物活性[J]. 高等学校化学学报, 2010, 31(4): 708. |
[9] | 申晓霞 徐胜臻 陈长水. N-硝基脲类化合物除草活性的3D-QSAR研究[J]. 高等学校化学学报, 2010, 31(12): 2419. |
[10] | 王红学, 李芳, 许丽萍, 李永红, 王素华, 李正名. 新(4′-三氟甲基嘧啶基)-2-苯磺酰脲衍生物的合成及生物活性[J]. 高等学校化学学报, 2010, 31(1): 64. |
[11] | 兰峰, 徐俊英, 李永红, 王素华, 李正名. 新型三唑啉酮类化合物的合成及生物活性[J]. 高等学校化学学报, 2009, 30(4): 712. |
[12] | 乌婧, 王宝雷, 李永红, 宋海滨, 王素华, 李正名. N-苄氧/烷氧苯基-4,6-二取代嘧啶胺类化合物的合成、晶体结构及除草活性 [J]. 高等学校化学学报, 2008, 29(8): 1583. |
[13] | 王雷, 唐蜜, 李文明, 李永红, 王素华, 李正名. 新型1,2,4-三唑啉酮类化合物的合成及生物活性[J]. 高等学校化学学报, 2008, 29(7): 1371. |
[14] | 郭万成, 谭海忠, 刘幸海, 李永红, 王素华, 李正名. 新三取代嘧啶苯磺酰脲衍生物的合成与生物活性[J]. 高等学校化学学报, 2008, 29(2): 319. |
[15] | 王宝雷, 李正名, 李永红, 王素华 . 4-烷氧/苄氧基苯基四唑和1,3,4-噁二唑类化合物的合成及除草活性[J]. 高等学校化学学报, 2008, 29(1): 90. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||